future pharma
Bioelectronic Medicines, a Rival to Traditional Pharmaceuticals?- An Interview with GSK's Imran Eba
August 29 by Gerald ClarkeThe words Bioelectronic medcine conjour up futuristic images of human-computer integegration that seem more sci-fi than science. GSK however view this as a promising medicinal area as demonstrated b...
Synthetic Biology: New Tools, New Approaches, New Thinking- Interview with Professor Paul Freemont
August 08 by Gerald ClarkeAs part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor Paul Freemont Chair in Protein Crystallography and Co-Founder and Co-...
Pharmaceuticals Companies Need Radical Transformation to be the Winners in 2020, According to KPMG’s Future Pharma Research
October 20 by Pharma IQ NewsGlobal pharmaceutical companies need to undergo a radical transformation of their investment and business strategies in order to reverse a prolonged period of disappointing business performance and...
Future Pharma: Five Strategies to Accelerate the Transformation of the Pharmaceutical Industry by 2020
October 20 by Pharmaceuticals & Biotechnology EditorThis paper explores some of the major challenges facing the pharmaceutical industry today. Four Major Challenges Facing the Pharmaceutical Industry: 1. Delivering shareholder/stakeholder value...
Bioelectronic Medicines, a Rival to Traditional Pharmaceuticals?- An Interview with GSK's Imran Eba
April 25 by Imran EbaGerald Clarke: Hello, everyone, I'm Gerald Clarke, Editor at Pharma IQ, www.pharma-iq.com. Today I'm joined by Imran Eba, Partner...
Synthetic Biology in the Pharma Industry- An Interview with Professor James Collins
April 25 by James CollinsGerald Clarke: Hello, I’m Gerald Clarke editor at Pharma IQ, www.pharma-iq.com. Today I’m joined by Professor James Collins, profes...
Synthetic Biology: New Tools, New Approaches, New Thinking- Interview with Professor Paul Freemont
April 25 by Paul FreemontGerald Clarke: Hello, I’m Gerald Clarke, editor at PharmaIQ. Today I’m joined by Professor Paul Freemont, Chair in Protein Cry...